Comentario editorial. Agentes antidiabéticos: ¿todo paciente diabético debe recibir un inhibidor de SGLT2?
Leído
1729
Vecesse ha leído el artículo
1161
Total PDF
568
Total HTML
Información del artículo
ISSN: X7351097Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 10 | 12 | 22 |
| 2025 5 | 14 | 16 | 30 |
| 2025 4 | 13 | 15 | 28 |
| 2025 3 | 13 | 10 | 23 |
| 2025 2 | 10 | 10 | 20 |
| 2025 1 | 10 | 12 | 22 |
| 2024 12 | 18 | 12 | 30 |
| 2024 11 | 15 | 12 | 27 |
| 2024 10 | 6 | 11 | 17 |
| 2024 9 | 7 | 13 | 20 |
| 2024 8 | 9 | 11 | 20 |
| 2024 7 | 10 | 13 | 23 |
| 2024 6 | 9 | 16 | 25 |
| 2024 5 | 11 | 8 | 19 |
| 2024 4 | 9 | 16 | 25 |
| 2024 3 | 9 | 16 | 25 |
| 2024 2 | 7 | 14 | 21 |
| 2024 1 | 10 | 26 | 36 |
| 2023 12 | 5 | 11 | 16 |
| 2023 11 | 8 | 31 | 39 |
| 2023 10 | 9 | 13 | 22 |
| 2023 9 | 10 | 31 | 41 |
| 2023 8 | 7 | 3 | 10 |
| 2023 7 | 26 | 19 | 45 |
| 2023 6 | 13 | 24 | 37 |
| 2023 5 | 14 | 23 | 37 |
| 2023 4 | 6 | 15 | 21 |
| 2023 3 | 15 | 25 | 40 |
| 2023 2 | 10 | 18 | 28 |
| 2022 1 | 11 | 17 | 28 |
| 2022 12 | 8 | 23 | 31 |
| 2022 11 | 14 | 27 | 41 |
| 2022 10 | 16 | 24 | 40 |
| 2022 9 | 7 | 16 | 23 |
| 2022 8 | 8 | 16 | 24 |
| 2022 7 | 14 | 26 | 40 |
| 2022 6 | 10 | 16 | 26 |
| 2022 5 | 6 | 22 | 28 |
| 2022 4 | 14 | 22 | 36 |
| 2022 3 | 9 | 16 | 25 |
| 2022 2 | 7 | 18 | 25 |
| 2021 1 | 10 | 35 | 45 |
| 2021 12 | 10 | 26 | 36 |
| 2021 11 | 6 | 28 | 34 |
| 2021 10 | 6 | 33 | 39 |
| 2021 9 | 4 | 31 | 35 |
| 2021 8 | 2 | 22 | 24 |
| 2021 7 | 6 | 19 | 25 |
| 2021 6 | 2 | 10 | 12 |
| 2021 5 | 5 | 12 | 17 |
| 2021 4 | 20 | 45 | 65 |
| 2021 3 | 6 | 15 | 21 |
| 2021 2 | 2 | 12 | 14 |
| 2020 1 | 1 | 6 | 7 |
| 2020 12 | 1 | 6 | 7 |
| 2020 11 | 2 | 13 | 15 |
| 2020 10 | 7 | 26 | 33 |
| 2020 9 | 9 | 50 | 59 |
| 2020 8 | 32 | 73 | 105 |
Mostrar todo
